Tyrosine Kinase Inhibitors for Non-Small Cell Lung Cancer and Eye Metastasis: Disease Relapse or a New Entity?

Por ZAROGOULIDIS, Paul, LAMPAKI, Sofia, CHINELIS, Panos, LAZARIDIS, George, BAKA, Sofia, RAPTI, Aggeliki
Publicado no Med Hypothesis Discov Innov Ophthalmol (2016)

“Liquid elbows” due to afatinib administration

Por Zarogoulidis, Paul, Chinelis, Panos, Athanasiadou, Anastasia, Porpodis, Konstantinos, Kallianos, Anastasios, Rapti, Aggeliki, Trakada, Georgia, Velentza, Lemonia, Huang, Haidong, Tsiouda, Theodora, Hohenforst-Schmidt, Wolfgang
Publicado no Respir Med Case Rep (2017)

EGFR or PD-L1 decision for first line therapy in a case series of EGFR positive and PD-L1 >50%

Por Zarogoulidis, Paul, Chinelis, Panos, Efthymiou, Christofors, Athanasiadou, Anastasia, Mpikos, Vasilis, Papatsibas, George, Papadopoulos, Vasilis, Maragouli, Elena, Huang, Haidong, Trakada, Georgia, Kallianos, Anastasios, Veletza, Lemonia, Hohenforst-Schmidt, Wolfgang
Publicado no Respir Med Case Rep (2017)

Possible adverse effects of immunotherapy in non-small cell lung cancer; treatment and follow-up of three cases

Por Zarogoulidis, Paul, Chinelis, Panos, Athanasiadou, Anastasia, Tsiouda, Theodora, Trakada, Georgia, Kallianos, Anastasios, Veletza, Lemonia, Hatzibougias, Dimitris, Mihalopoulou, Electra, Goupou, Eirini, Kosmidis, Christoforos, Sardeli, Chrysanthi, Huang, Haidong, Hohenforst-Schmidt, Wolfgang
Publicado no Respir Med Case Rep (2017)